Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 9,066,621 | 4,311,092 | -4,755,529 | $445.72M | $237.11M | 15.92% | -$208.61M |
| Krystal Biotech, Inc.(KRYS) | 673,505 | 632,005 | -41,500 | $173.98M | $234.90M | 15.77% | +$60.92M |
| Stoke Therapeutics, Inc.(STOK) | 4,164,120 | 3,945,920 | -218,200 | $135.58M | $129.11M | 8.67% | -$6.47M |
| Immunome, Inc.(IMNM) | 5,558,885 | 4,911,590 | -647,295 | $121.57M | $104.08M | 6.99% | -$17.50M |
| Nurix Therapeutics, Inc.(NRIX) | 7,732,808 | 4,073,787 | -3,659,021 | $119.86M | $98.83M | 6.64% | -$21.03M |
| Absci Corporation | 8,253,316 | 6,739,675 | -1,513,641 | $24.76M | $78.11M | 5.24% | +$53.35M |
| Annexon, Inc.(ANNX) | 14,549,768 | 11,869,877 | -2,679,891 | $80.61M | $67.78M | 4.55% | -$12.83M |
| REGENXBIO Inc.(RGNX) | 4,368,804 | 4,368,804 | 0 | $36.61M | $52.34M | 3.51% | +$15.73M |
| Shattuck Labs, Inc.(STTK) | 5,539,724 | 6,892,033 | +1,352,309 | $35.62M | $47.83M | 3.21% | +$12.21M |
| Neurogene Inc.(NGNE) | 1,459,599 | 1,412,199 | -47,400 | $29.43M | $44.41M | 2.98% | +$14.99M |
| Beam Therapeutics Inc.(BEAM) | 1,237,659 | 1,164,259 | -73,400 | $29.49M | $39.96M | 2.68% | +$10.46M |
| AgomAb Therapeutics NVADS(AGMB) | 156,250 | 2,733,926 | +2,577,676 | $1.64M | $35.49M | 2.38% | +$33.85M |
| Fate Therapeutics, Inc.(FATE) | 12,872,946 | 12,872,946 | 0 | $15.45M | $34.76M | 2.33% | +$19.31M |
| IDEAYA Biosciences, Inc.(IDYA) | 521,117 | 640,202 | +119,085 | $17.36M | $23.86M | 1.60% | +$6.50M |
| Silence Therapeutics plcADS(SLN) | 2,164,777 | 2,164,777 | 0 | $11.41M | $23.77M | 1.60% | +$12.36M |
| Cogent Biosciences, Inc.(COGT) | 688,036 | 503,321 | -184,715 | $26.48M | $19.48M | 1.31% | -$7.00M |
| Solid Biosciences Inc | 2,011,895 | 1,948,695 | -63,200 | $14.49M | $19.47M | 1.31% | +$4.98M |
| Nuvation Bio Inc.CL A(NUVB) | 3,153,256 | 3,031,009 | -122,247 | $13.53M | $17.22M | 1.16% | +$3.69M |
| Celldex Therapeutics, Inc.(CLDX) | 261,508 | 433,921 | +172,413 | $8.30M | $16.15M | 1.08% | +$7.85M |
| Climb Bio, Inc.(CLYM) | 0 | 1,226,330 | +1,226,330 | $0 | $15.99M | 1.07% | +$15.99M |
| ALX Oncology Holdings Inc.(ALXO) | 7,964,188 | 7,392,504 | -571,684 | $15.97M | $15.30M | 1.03% | -$665.7K |
| BioMarin Pharmaceutical Inc.(BMRN) | 173,859 | 265,169 | +91,310 | $9.82M | $15.17M | 1.02% | +$5.35M |
| Xenon Pharmaceuticals Inc.(XENE) | 262,674 | 229,374 | -33,300 | $15.27M | $13.85M | 0.93% | -$1.43M |
| Zymeworks Inc.(ZYME) | 491,654 | 491,654 | 0 | $12.31M | $12.85M | 0.86% | +$540.8K |
| ADC Therapeutics SASHS(ADCT) | 15,470,502 | 11,526,710 | -3,943,792 | $58.01M | $12.33M | 0.83% | -$45.68M |
| Aura Biosciences, Inc.(AURA) | 0 | 1,666,667 | +1,666,667 | $0 | $11.83M | 0.79% | +$11.83M |
| Odyssey Therapeutics Inc | 0 | 425,000 | +425,000 | $0 | $7.95M | 0.53% | +$7.95M |
| LivaNova PLCSHS(LIVN) | 108,354 | 93,154 | -15,200 | $6.89M | $7.66M | 0.51% | +$773.1K |
| Establishment Labs Holdings Inc.(ESTA) | 103,464 | 88,964 | -14,500 | $5.87M | $7.63M | 0.51% | +$1.76M |
| CeriBell, Inc.(CBLL) | 386,786 | 386,786 | 0 | $7.09M | $7.52M | 0.51% | +$433.2K |
| DBV Technologies S.A.ADS(DBVT) | 491,340 | 410,440 | -80,900 | $10.26M | $6.73M | 0.45% | -$3.53M |
| Insmed Incorporated(INSM) | 0 | 51,234 | +51,234 | $0 | $5.46M | 0.37% | +$5.46M |
| Prime Medicine, Inc.(PRME) | 1,590,832 | 1,389,632 | -201,200 | $5.54M | $5.13M | 0.34% | -$408.4K |
| Atara Biotherapeutics Inc | 441,701 | 441,701 | 0 | $2.09M | $5.07M | 0.34% | +$2.98M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 700,000 | 611,400 | -88,600 | $5.07M | $4.04M | 0.27% | -$1.03M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 415,710 | 362,010 | -53,700 | $5.27M | $3.92M | 0.26% | -$1.35M |
| Ardelyx Inc | 733,350 | 641,750 | -91,600 | $4.39M | $3.27M | 0.22% | -$1.12M |
| Invivyd, Inc.(IVVD) | 2,648,659 | 2,597,759 | -50,900 | $3.44M | $2.27M | 0.15% | -$1.18M |
| Pliant Therapeutics, Inc.(PLRX) | 772,126 | 772,126 | 0 | $972.9K | $880.2K | 0.06% | -$92.7K |